Scholars Central

Conference abstractPublished 23 Jul 2018

Palladium nanoparticles selectively induce apoptosis in lung cancer cells through reactive oxygen species

Authors: Ferda Ari, Merve Erkisa, Gulay Buyukkoroglu, Behiye Senel, Veysel T Yılmaz, Engin Ulukaya

Uludag University, Bursa, Turkey Istinye University, Istanbul, Turkey Anadolu University, EskiÃ?Â?ehir, Turkey

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

One of the leading causes of cancer-associated deaths in most men and women in the world is lung cancer. Current standards of care for lung cancer include surgery, radiation, and chemotherapy. With the rapid development of nanotechnology, the nanomaterials lead to peopleâÂ?Â?s attention for probable toxic effect. In the present study, it was aimed to evaluate the cytotoxic and apoptotic effects of palladium (II) in PEGâÂ?Â?DSPE micelle formulation (PdNP) on lung cancer. The non-small cell lung cancer (NSLC) cell line H1299 was treated with different concentration of PdNP (0.5âÂ?Â?5Ã?¼g/ml) effects on cell viability were detected by SRB and ATP assay at 48 h. Nuclear morphology and plasma membrane integrity were visualized fluorescence staining for 12 h and 24 h. The induction of apoptosis was confirmed by (caspase 3/7 activity, annexin-V, mitochondria membrane potential (MMP), Bcl-2 activation, JC-1 dye, cell cycle and oxidative stress level) by flow cytometry at the concentration (1 Ã?¼g/ml) for 24 h and 48 h. PdNP showed anti-growth effect against H1299 cell in a dose dependent manner. Pyknotic nuclei and sub-G1 hypodiploid cells well-known markers for apoptosis, was observed after treatment with PdNP. However, PdNP induced a mitochondria-dependent apoptotic pathway via modulation of Bcl-2 expressions, resulting in the disruption of mitochondrial membrane potential. PdNP induced reactive oxygen species generation. PdNP induces cytotoxicity and apoptosis in H1299 cancer cells, and this effect is likely mediated through ROS generation and mitochondrial mechanism. Therefore, PdNP may be used for the treatment of non-small cell lung cancer that is extremely resistant to conventional therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Ferda Ari”
  • BylineArticles whose byline prints “Merve Erkisa”
  • BylineArticles whose byline prints “Gulay Buyukkoroglu”
  • BylineArticles whose byline prints “Behiye Senel”
  • BylineArticles whose byline prints “Veysel T Yılmaz”
  • BylineArticles whose byline prints “Engin Ulukaya”